Clonit


Developer, manufacturer and distributor of in vitro diagnostic (IVD) reagents and instruments for molecular diagnostics. Core activities include design and production of real-time PCR assays and panels, automated magnetic-bead nucleic acid extraction systems and associated reagent kits, electrophoresis-based genetic tests, and immunochromatographic rapid tests. The company holds ISO 9001 and ISO 13485 certifications and is certified under EU IVD quality management requirements.

Industries

Biotechnology
Genetics
Health Diagnostics
Manufacturing
Biotechnology Research

Nr. of Employees

small (1-50)


Products

CloNext 12 Automated Nucleic Acid Purification System

Automated magnetic-bead based platform for nucleic acid extraction (1–12 samples, walk-away automation) used with dedicated reagent kits.

CloNext 24 Automated Nucleic Acid Purification System

Automated magnetic-bead based platform for higher throughput nucleic acid extraction (1–24 samples).

quanty West Nile Virus (RT-04) real-time PCR kit

CE-IVD real-time PCR kit for detection and quantification of West Nile Virus.

Gluten DQuick DResolution (HLA typing) RT-59v3

Real-time PCR HLA typing kit for assessment of celiac disease risk (HLA-DQ2 / HLA-DQ8 / HLA-DR).

Selected rapid immunochromatographic test cards (examples)

Lateral flow rapid tests for pathogens and analytes (e.g., Adenovirus card, Clostridium difficile toxin A/B, Rotavirus, Strep A/B).

CloNext Viral Nucleic Acid Extraction kit - OP02003-48

The CloNext Viral Nucleic Acid Extraction kit is designed for extracting viral nucleic acids from plasma, serum or cell-free body fluids using unique magnetic beads technology. It is used in combination with CloNext series of automatic instruments to achieve superior product quality, consistent and high product yield, and reproducible results.

View All Products

Expertise Areas

  • Molecular diagnostics (real-time PCR)
  • Automated nucleic acid extraction and sample prep
  • Genotyping and allelic discrimination
  • Infectious disease and tropical pathogen diagnostics
  • Show More (5)

Key Technologies

  • Real-time PCR (qPCR) multiplex assays
  • Automated magnetic-bead nucleic acid extraction
  • Capillary electrophoresis
  • Gel electrophoresis
  • Show More (4)

News & Updates

Announcement of the acquisition of Dia.Pro described as a strategic milestone to strengthen the company's position in in-vitro diagnostics.

Participation and exhibition at MEDICA 2025 trade fair (Hall 3 – C60) to present molecular diagnostics portfolio.

Announcement of participation at the XXVIII National SIGU Congress to present molecular diagnostic solutions.

Release announcement for an updated HLA typing solution for celiac disease risk assessment.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.